Clinical Trials

34 enrolled 6 charts

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT05477823 2026-06-02

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT05787587 2026-06-02

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

216 enrolled

Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related, Breast Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00352924 2026-06-01

Agriculture Health Study

GenitourinaryLymphoidPlasma cell

89,655 enrolled

Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT03012321 2026-06-01

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

70 enrolled

Prostatic Neoplasms

NCT03600350 2026-06-01

pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

19 enrolled 10 charts

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT05367440 2026-06-01

PETRANHA

174 enrolled

Prostatic Neoplasms

NCT05720910 2026-06-01

FRONE

BreastGastrointestinalGenitourinaryThoracic

720 enrolled

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06257264 2026-06-01

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

BreastGastrointestinalGenitourinaryGynecologicThoracic

103 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01251861 2026-05-29

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

108 enrolled 16 charts

Prostatic Neoplasms

NCT03173924 2026-05-29

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

96 enrolled

Disease, Prostatic Neoplasms

NCT04530552 2026-05-29

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

34 enrolled 11 charts

Prostatic Neoplasms

NCT04541030 2026-05-29

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies

241 enrolled

Prostatic Neoplasms

NCT06964412 2026-05-29

The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy

36 enrolled

Prostatic Neoplasms

NCT02893917 2026-05-28

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

90 enrolled 19 charts

Prostatic Neoplasms

NCT04190446 2026-05-28

A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

84 enrolled

Prostatic Neoplasms

NCT04514484 2026-05-28

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

8 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06395753 2026-05-28

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

55 enrolled

Prostatic Neoplasms

NCT06523777 2026-05-28

PRISM

350 enrolled

Prostatic Neoplasms

NCT04070209 2026-05-27

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

66 enrolled

Prostatic Neoplasms

NCT04720157 2026-05-27

PSMAddition

1,140 enrolled

Prostatic Neoplasms

NCT05849298 2026-05-27

PSMACare

49 enrolled

Prostatic Neoplasms

NCT06120491 2026-05-27

EvoPAR-PR01

1,889 enrolled

Prostatic Neoplasms

NCT07608419 2026-05-27

CZECH-PSMA

400 enrolled

Prostatic Neoplasms

NCT02177292 2026-05-26

SIB

80 enrolled

Prostatic Neoplasms

NCT02465060 2026-05-26

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellThoracic

6,452 enrolled 1 FDA

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT03582774 2026-05-26

PSMA SRT

193 enrolled

Phase 2/3 Active not recruiting

Prostatic Neoplasms

NCT04263025 2026-05-26

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

100 enrolled

Prostatic Neoplasms

NCT05496959 2026-05-26

LUNAR

93 enrolled

Prostatic Neoplasms

NCT06533059 2026-05-26

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

BreastGenitourinaryGynecologic

110 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07607431 2026-05-26

AWARE

214 enrolled

Lymphedema, Prostatic Neoplasms

NCT02799706 2026-05-22

PEGASUS

885 enrolled

Prostatic Neoplasms

NCT04007770 2026-05-22

Acupuncture Pilot Study for Cancer-related Cognitive Function

BreastGastrointestinalGenitourinary

48 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05416996 2026-05-22

A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer

88 enrolled

Prostatic Neoplasms

NCT06238479 2026-05-22

EXCEED